Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian S Zagon

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Brain Research Bulletin|May 4, 2004
Gene expression of OGFr in the developing and adult rat brain and cerebellumIan S Zagon, Patricia J McLaughlin
Neuropeptides|September 20, 2005
Opioids and differentiation in human cancer cellsIan S Zagon, Patricia J McLaughlin
Biochemical Pharmacology|June 30, 2015
Duration of opioid receptor blockade determines biotherapeutic responsePatricia J McLaughlin, Ian S Zagon
Experimental Biology and Medicine (Maywood, N.J.)|December 14, 2018
Intermittent blockade of OGFr and treatment of autoimmune disordersIan S Zagon, Patricia J McLaughlin
World Journal of Gastroenterology|March 8, 2014
Opioid growth factor and the treatment of human pancreatic cancer: a reviewIan S Zagon, Patricia J McLaughlin
Neuropeptides|May 16, 2003
Opioids and the apoptotic pathway in human cancer cellsIan S Zagon, Patricia J McLaughlin
International Journal of Oncology|May 13, 2004
Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cellsIan S Zagon, Patricia J McLaughlin
International Journal of Oncology|July 6, 2006
Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancersIan S Zagon, Patricia J McLaughlin
Biochemical Pharmacology|June 13, 2012
The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and diseasePatricia J McLaughlin, Ian S Zagon
International Journal of Oncology|May 11, 2006
Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptorPatricia J McLaughlin, Ian S Zagon
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Brain Research Bulletin|May 4, 2004
Gene expression of OGFr in the developing and adult rat brain and cerebellumIan S Zagon, Patricia J McLaughlin
Neuropeptides|September 20, 2005
Opioids and differentiation in human cancer cellsIan S Zagon, Patricia J McLaughlin
Biochemical Pharmacology|June 30, 2015
Duration of opioid receptor blockade determines biotherapeutic responsePatricia J McLaughlin, Ian S Zagon
Experimental Biology and Medicine (Maywood, N.J.)|December 14, 2018
Intermittent blockade of OGFr and treatment of autoimmune disordersIan S Zagon, Patricia J McLaughlin
World Journal of Gastroenterology|March 8, 2014
Opioid growth factor and the treatment of human pancreatic cancer: a reviewIan S Zagon, Patricia J McLaughlin
Neuropeptides|May 16, 2003
Opioids and the apoptotic pathway in human cancer cellsIan S Zagon, Patricia J McLaughlin
International Journal of Oncology|May 13, 2004
Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cellsIan S Zagon, Patricia J McLaughlin
International Journal of Oncology|July 6, 2006
Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancersIan S Zagon, Patricia J McLaughlin
Biochemical Pharmacology|June 13, 2012
The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and diseasePatricia J McLaughlin, Ian S Zagon
International Journal of Oncology|May 11, 2006
Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptorPatricia J McLaughlin, Ian S Zagon
Pageof 13